Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
01/20/1999 | EP0675965A4 Polynucleotide immobilized support. |
01/20/1999 | EP0642352B1 TRUNCATED TISSUE FACTOR AND FVIIa OR FVII ACTIVATOR FOR BLOOD COAGULATION |
01/20/1999 | EP0584343B1 Recombinant calf intestinal alkaline phosphatase |
01/20/1999 | EP0507904B1 Method for evaluating the adequacy of clinical specimens for hybridization assays and kit for performing the evaluation |
01/20/1999 | CN2304911Y Automatic blood sedimentation gauge |
01/20/1999 | CN2304910Y Instrument for testing fine hair thickness on animal fur |
01/20/1999 | CN1205770A Method and device for measuring electromagnetic waves emanating from melt |
01/20/1999 | CN1205740A Diagnosis and treatment of Aur-1 and/or Aur-2 related disorders |
01/20/1999 | CN1205436A Blood analysis instrument dilution and its prepn. method |
01/20/1999 | CN1205435A Steel liquid directly fixing aluminium sensor |
01/19/1999 | USRE36054 For testing or monitoring of blood without activation of platelets; medical diagnosis |
01/19/1999 | US5861757 To measure a dielectric constant of a sample having a geometrical shape |
01/19/1999 | US5861629 Method of and device for the quantitative detection of material in a sample |
01/19/1999 | US5861497 Trabecular meshwork induced glucocorticoid response (TIGR) nucleic acid molecules |
01/19/1999 | US5861496 Nucleic acid and amino acid sequences of a novel squalene epoxidase and to the use of these sequences in the diagnosis, prevention, and treatment of diseases such as hypercholesterolemia and atherosclerosis. |
01/19/1999 | US5861379 Chimeric fatty body-pro-GRF analogs with increased biological potency |
01/19/1999 | US5861319 Immobilization of specific binding assay reagents |
01/19/1999 | US5861311 Preserved, non-infectious control cells prepared by the modulation or modification of normal leukocytes |
01/19/1999 | US5861309 Amino acid sequences encoding it, vectors for its expression in yeast, bacterial, and mammalian cells; research into the characterization of the pharmacology of individual human alpha 1 receptor subtypes |
01/19/1999 | US5861308 Isolated nucleic acids associated with T cell activation and uses thereof |
01/19/1999 | US5861301 Recombinant kinase insert domain containing receptor and gene encoding same |
01/19/1999 | US5861285 Fusion dna sequence, obtained by fusing a gene coding for another useful protein to a fragment of a maga gene coding for a protein bound to an organic membrane for covering magnetic particles produced in cells of a magnetic bacterium amb-1 |
01/19/1999 | US5861276 CDNAS encoding murine antibody against human plasma apolipoprotein B-100 |
01/19/1999 | US5861274 Nucleic acids encoding peroxisome proliferator-activated receptor |
01/19/1999 | US5861268 Method for induction of tumor cell apoptosis with chemical inhibitors targeted to 12-lipoxygenase |
01/19/1999 | US5861266 Treatment of diabetes mellitus and insulin receptor signal transduction |
01/19/1999 | US5861265 Enzyme labeled binding assay with absorbent material and developing solution and substrate for enzyme for immunoassay |
01/19/1999 | US5861264 Determination presence of autoantibodies against mast cell specific proteins such as tryptase and chymase |
01/19/1999 | US5861263 Useful in diagnosis of amebiasis, a parasitic disease provoked by the protozoan entamoeba histolytica |
01/19/1999 | US5861262 Method of the specific immunoassay of human plasma glutathione peroxidase, kit for its implementation, oligopeptides and antibodies specific for the method |
01/19/1999 | US5861260 Contacting sample from patient with a pure centrosomal protein cp140 polypeptide fragment so that it will bind to autoantibodies, detecting autoantibody:cp140 complexes, if present, indicates disease |
01/19/1999 | US5861259 Immunoassays for human cyclin E |
01/19/1999 | US5861256 Methods and apparatus for detection and discrimination of multiple analytes using flourescent technology |
01/19/1999 | US5861253 Reacting with labeled antibody; separation; detection; determining genetic defects |
01/19/1999 | US5861252 Method of analysis or assay for polynucleotides and analyzer or instrument for polynucleotides |
01/19/1999 | US5861250 Protecting nucleic acids and methods of analysis |
01/19/1999 | US5861243 Amino acid sequences |
01/19/1999 | US5861241 Monoclonal antibodies for detecting Norwalk virus |
01/19/1999 | US5861238 Methods for partitioning advanced glycosylation endproducts |
01/19/1999 | US5861228 Cracking property determination |
01/19/1999 | US5861157 An immunogenic fragment obtained from a bacterial protein capable of eliciting antibody response |
01/19/1999 | US5861139 Method and composition for labeling proteins, peptides and amino acids, including antibodies, with a variety of metals ions (tin), including radioisotopes |
01/19/1999 | US5861092 Oxidation, measurement of electromotive force |
01/19/1999 | US5860937 Evacuated sample collection tube with aqueous additive |
01/19/1999 | CA2105382C Recombinant hybrid porin epitopes |
01/19/1999 | CA2059533C Microwave apparatus and method for measuring fluid mixtures |
01/19/1999 | CA2024206C Test device and method of assaying for fructoasmines |
01/19/1999 | CA1340327C Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
01/19/1999 | CA1340322C Human papillomavirus type 41, its dna and the proteins encoded therefrom |
01/19/1999 | CA1340320C Immunodiagnostic device |
01/18/1999 | CA2237160A1 Gida1 |
01/18/1999 | CA2237147A1 Novel ratb |
01/18/1999 | CA2237143A1 Novel rata |
01/18/1999 | CA2237140A1 Novel tarf |
01/18/1999 | CA2237050A1 Histidine kinase |
01/18/1999 | CA2237043A1 Response regulator |
01/17/1999 | CA2237045A1 Novel glycogen phosphorylase |
01/16/1999 | CA2659003A1 Methods of diagnosing muscle damage |
01/16/1999 | CA2237784A1 Novel compounds |
01/15/1999 | CA2220849A1 A human pelota homolog |
01/14/1999 | WO1999001843A1 Method for remote sensing analysis by decorrelation statistical analysis and hardware therefor |
01/14/1999 | WO1999001768A1 Peroxidase-catalysed fluorescence |
01/14/1999 | WO1999001767A1 Reagent for detecting and monitoring viral infections |
01/14/1999 | WO1999001766A1 A metal particle, its preparation and use, and a material or device comprising the metal particle |
01/14/1999 | WO1999001765A1 METHODS OF INHIBITING OR ENHANCING THE TGFβ-SMAD SIGNALING PATHWAY |
01/14/1999 | WO1999001764A2 METHOD FOR DETERMINING GnRH RECEPTORS |
01/14/1999 | WO1999001763A2 p53 AS A REGULATOR OF CELL DIFFERENTIATION |
01/14/1999 | WO1999001762A1 Method and device for detecting undesired matter in eggs |
01/14/1999 | WO1999001761A1 Apparatus and methods for gas sampling |
01/14/1999 | WO1999001754A1 Apparatus and method for measuring the content of intramuscular fat in carcasses or parts thereof |
01/14/1999 | WO1999001741A1 Molten glass viscosity and/or level meter |
01/14/1999 | WO1999001739A1 Soil sampling for oil and gas exploration |
01/14/1999 | WO1999001738A2 Heparin binding-epidermal growth factor in the diagnosis of interstitial cystitis |
01/14/1999 | WO1999001733A1 Organic solvent vapor detector |
01/14/1999 | WO1999001582A1 Screening methods using an atpase protein from a virus of the flaviviridae family |
01/14/1999 | WO1999001568A1 Parkinson's disease tests |
01/14/1999 | WO1999001567A2 Methods and compositions for a deubiquitinating enzyme and variants thereof |
01/14/1999 | WO1999001559A1 Novel mapk kinase |
01/14/1999 | WO1999001557A1 Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy |
01/14/1999 | WO1999001554A1 Mammalian secretory peptide-9 |
01/14/1999 | WO1999001552A1 Fluorescent proteins as cell-type specific reporter |
01/14/1999 | WO1999001542A1 IKK-β PROTEINS, NUCLEIC ACIDS AND METHODS |
01/14/1999 | WO1999001541A1 IKK-α PROTEINS, NUCLEIC ACIDS AND METHODS |
01/14/1999 | WO1999001539A1 A process for purification of pcr test samples |
01/14/1999 | WO1999001477A1 Method for diagnosing systemic lupus erythematosus |
01/14/1999 | WO1999001476A1 CRYSTAL STRUCTURES OF ANTI-FACTOR IX Fab FRAGMENTS AND METHODS OF USE FOR PEPTIDOMIMETIC DESIGN |
01/14/1999 | WO1999001473A2 Anti-bacterial methods and materials |
01/14/1999 | WO1999001471A1 Nik proteins, nucleic acids and methods |
01/14/1999 | WO1999001464A1 Componds and methods for treating and screening viral reactivation |
01/14/1999 | WO1999001447A1 Diaminorhodamine derivatives |
01/14/1999 | WO1999001409A1 Method for inferring protein functions with the use of ligand data base |
01/14/1999 | WO1999001085A2 Autoimmune inner ear disease antigen and diagnostic assay |
01/14/1999 | WO1998050555A3 Enterococcus faecalis polynucleotides and polypeptides |
01/14/1999 | WO1998038212A3 Chimeric polypeptides containing chemokine domains |
01/14/1999 | WO1998035020A3 Methods for modulating hematopoiesis and vascular growth |
01/14/1999 | WO1998021333A3 Nucleic acid encoding schwannomin-binding-proteins and products related thereto |
01/14/1999 | DE19830727A1 Physical or chemical reactions determining arrangement e.g. as in biosensor, chemical sensor |
01/14/1999 | DE19824025A1 Control of web material production |
01/14/1999 | DE19816187A1 Analysis of emissions from material surfaces |
01/14/1999 | DE19729544A1 Ancrod spezifische monoklonale Antikörper, Antikörperfragmente, deren Mischung oder Derivate und deren Verwendung Ancrod specific monoclonal antibodies, antibody fragments, their mixture or their derivatives and the use thereof |